BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26618447)

  • 21. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of L-thyroxine (L-T4) therapy on the volume of the thyroid gland and nodules in patients with euthyroid nodular goiter (ENG)].
    Diacinti D; Salabè GB; Olivieri A; D'Erasmo E; Tomei E; Lotz-Salabè H; De Martinis C
    Minerva Med; 1992 Nov; 83(11):745-51. PubMed ID: 1461545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of metformin on the body composition in subjects with risk factors for type 2 diabetes.
    Rodríguez-Moctezuma JR; Robles-López G; López-Carmona JM; Gutiérrez-Rosas MJ
    Diabetes Obes Metab; 2005 Mar; 7(2):189-92. PubMed ID: 15715892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.
    Sathyapalan T; Cho LW; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):931-5. PubMed ID: 18410553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome.
    Blanc E; Ponce C; Brodschi D; Nepote A; Barreto A; Schnitman M; Fossati P; Salgado P; Cejas C; Faingold C; Musso C; Brenta G
    Metab Syndr Relat Disord; 2015 Jun; 13(5):221-6. PubMed ID: 25789844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with metformin and fenofibrate for insulin resistance in obesity.
    Li XM; Li Y; Zhang NN; Xie YH; Shi YQ
    J Int Med Res; 2011; 39(5):1876-82. PubMed ID: 22117989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.
    Lazurova I; Dravecka I; Kraus V; Petrovicova J
    Bratisl Lek Listy; 2004; 105(5-6):207-10. PubMed ID: 15535111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism.
    Krysiak R; Szkrobka W; Okopien B
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):205-8. PubMed ID: 25658660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.
    Rotondi M; Cappelli C; Magri F; Botta R; Dionisio R; Iacobello C; De Cata P; Nappi RE; Castellano M; Chiovato L
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):378-81. PubMed ID: 21521311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria.
    Konrad K; Datz N; Engelsberger I; Grulich-Henn J; Hoertenhuber T; Knauth B; Meissner T; Wiegand S; Woelfle J; Holl RW;
    Pediatr Diabetes; 2015 Nov; 16(7):529-37. PubMed ID: 25131985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
    Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
    Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Metformin treatment with or without life style changes in patients with polycystic ovary syndrome].
    Petrányi G; Zaoura-Petrányi M
    Orv Hetil; 2011 Apr; 152(16):628-32. PubMed ID: 21454179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin and thyroid disease.
    Meng X; Xu S; Chen G; Derwahl M; Liu C
    J Endocrinol; 2017 Apr; 233(1):R43-R51. PubMed ID: 28196954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and placebo therapy both improve weight management and fasting insulin in obese insulin-resistant adolescents: a prospective, placebo-controlled, randomized study.
    Wiegand S; l'Allemand D; Hübel H; Krude H; Bürmann M; Martus P; Grüters A; Holl RW
    Eur J Endocrinol; 2010 Oct; 163(4):585-92. PubMed ID: 20639355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M; Kavŭrdzhikova S
    Akush Ginekol (Sofiia); 2006; 45(6):29-35. PubMed ID: 17168480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.